(Q28369240)

2

0 references

J Hurley

3

0 references

A Marini

4

0 references

S Lai

Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study

5

0 references

language of work or name

English

0 references

publication date

1 February 2000

0 references

published in

Cancer

0 references

volume

88

0 references

issue

3

0 references

page(s)

584-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Tamoxifen: is it useful in the treatment of patients with metastatic melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Oestrogen receptors in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Update results of vindesine as a single agent in the therapy of advanced malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

A multicentre phase II trial of vindesine in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23

Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000201%2988%3A3%3C584%3A%3AAID-CNCR14%3E3.0.CO%3B2-%23